Resistance to helminth infection: The case for interleukin-5 - Dependent mechanisms

Journal of Infectious Diseases

Volumn 190, Issue 3, 2004, Pages 427-429

  Maizels, Rick M ^a   Balic, Adam ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5;

CELL ACTIVATION; CELL SURVIVAL; CYTOKINE PRODUCTION; DEGRANULATION; EOSINOPHIL; HELMINTHIASIS; HUMAN; IMMUNE RESPONSE; NONHUMAN; NOTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHISTOSOMA MANSONI; TOXOCARA CANIS; TRICHINELLA SPIRALIS;

ANIMALS; HELMINTHIASIS; HELMINTHS; HUMANS; INTERLEUKIN-5; MICE; NECATOR AMERICANUS; NECATORIASIS; PAPUA NEW GUINEA;

EID: 3242778572     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422262     Document Type: Note

References (41)

1. Brown TR. Studies on trichinosis, with especial reference to the increase of the eosinophilic cells in the blood and the muscle, the origin of these cells and their diagnostic importance. J Exp Med 1898; 3:315-47.
2. Butterworth AE, Sturrock RF, Houba V, Mahmoud AA, Sher A, Rees PH. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature 1975; 256:727-9.
3. Mahmoud AAF, Warren KS, Peters PA. A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med 1975; 142: 805-13.
4. Capron M, Spiegelberg HL, Prin L, et al. Role of IgE receptors in effector function of human eosinophils. J Immunol 1984; 132:462-8.
5. Hagan P, Wilkins HA, Blumenthal UJ, Hayes RJ, Greenwood BM. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol 1985; 7:625-32.
6. Kazura JW, Grove DI. Stage-specific antibody-dependent eosinophil-mediated destruction of Trichinella spiralis. Nature 1978; 274:588-9.
7. Sanderson CJ, O'Garra A, Warren DJ, Klaus GGB. Eosinophil differentiation factor also has B-cell growth factor activity, proposed name interleukin 4. Proc Natl Acad Sci USA 1986; 83:437-40.
8. Sher A, Coffman RL, Hieny S, Cheever AW. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol 1990; 145:3911-6.
9. Herndon FJ, Kayes SG. Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection. J Immunol 1992; 149:3642-7.
10. Betts CJ, Else KJ. Mast cells, eosinophils and antibody-mediated cellular cytotoxicity are not critical in resistance to Trichuris muris. Parasite Immunol 1999; 21:45-52.
11. Takamoto M, Ovington KS, Behm CA, Sugane K, Young IG, Matthaei KI. Eosinophilia, parasite burden and lung damage in Toxocara canis infection in C57Bl/6 mice genetically deficient in IL-5. Immunology 1997; 90:511-7.
12. Behm CA, Ovington KS. The role of eosinophils in parasitic helminth infections: insights from genetically-modified mice. Parasitol Today 2000; 16:202-9.
13. Meeusen ENT, Balic A. Do eosinophils have a role in the killing of helminth parasites? Parasitol Today 2000; 16:95-101.
14. Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 2004; 113:30-47.
15. Quinnell RJ, Pritchard DI, Raiko A, Brown AP, Shaw M-A. Immune responses in human necatoriasis: association between interleukin-5 responses and resistance to reinfection. J Infect Dis 2004; 190:430-8 (in this issue).
16. Roberts M, Butterworth AE, Kimani G, et al. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to infection. Infect Immun 1993; 61:4984-93.
17. Medhat A, Shehata M, Bucci K, et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 1998; 178:512-9.
18. Shin E-H, Osada Y, Chai J-Y, Matsumoto N, Takatsu K, Kojima S. Protective roles of eosinophils in Nippostrongylus brasiliensis infection. Int Arch Allergy Immunol 1997; 114(Suppl 1):45-50.
19. Daly CM, Mayrhofer G, Dent LA. Trapping and immobilization of Nippostrongylus brasiliensis larvae at the site of inoculation in primary infections of interleukin-5 transgenic mice. Infect Immun 1999; 67:5315-23.
20. Dent LA, Daly CM, Mayrhofer G, et al. Interleukin-5 transgenic mice show enhanced resistance to primary infections with Nippostrongylus brasiliensis but not primary infections with Toxocara canis. Infect Immun 1999; 67:989-93.
21. Martin C, Le Goff L, Ungeheuer M-N, Vuong PN, Bain O. Drastic reduction of a filarial infection in eosinophilic interleukin-5 transgenic mice. Infect Immun 2000; 68:3651-6.
22. Hokibara S, Takamoto M, Tominaga A, Takatsu K. Marked eosinophilia in interleukin-5 transgenic mice fails to prevent Trichinella spiralis infection. J Parasitol 1997; 83:1186-9.
23. Korenaga M, Hitoshi Y, Yamaguchi N, Sato Y, Takatsu K, Tada I. The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice. Immunology 1991; 72:502-7.
24. Sasaki O, Sugaya H, Ishida K, Yoshimura K. Ablation of eosinophils with anti-IL-5 antibody enhances the survival of intracranial worms of Angiostrongylus cantonensis in the mouse. Parasite Immunol 1993; 15:349-54.
25. Le Goff L, Loke P, Ali HF, Taylor DW, Allen JE. Interleukin-5 is essential for vaccine-mediated immunity but not innate resistance to a filarial parasite. Infect Immun 2000; 68:2513-7.
26. Vallance BA, Matthaei KI, Sanovic S, Young IG, Collins SM. Interleukin-5 deficient mice exhibit impaired host defence against challenge Trichinella spiralis infections. Parasite Immunol 2000; 22:487-92.
27. Tominaga A, Takaki S, Koyama N, et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med 1991; 173:429-37.
28. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996; 4:15-24.
29. Finkelman FD, Holmes J, Katona IM, et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8:303-33.
30. Al-Qaoud KM, Pearlman E, Hartung T, Klukowski J, Fleischer B, Hoerauf A. A new mechanism for IL-5-dependent helminth control: neutrophil accumulation and neutrophil-mediated worm encapsulation in murine filariasis are abolished in the absence of IL-5. Int Immunol 2000; 12:899-908.
31. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TI. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182:1169-74.
32. Foster PS, Mould AW, Yang M, et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 2001; 179:173-81.
33. Berger RB, Blackwell NM, Lass JH, Diaconu E, Pearlman E. IL-4 and IL-13 regulation of ICAM-1 expression and eosinophil recruitment in Onchocerca volvulus keratitis. Invest Ophthalmol Vis Sci 2002; 43:2992-7.
34. Dombrowicz D, Capron M. Eosinophils, allergy and parasites. Curr Opin Immunol 2001; 13:716-20.
35. Shinkai K, Mohrs M, Locksley RM. Helper T cells regulate type-2 innate immunity in vivo. Nature 2002; 420:825-9.
36. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004; 20:267-77.
37. Ohno I, Nitta Y, Yamauchi K, et al. Transforming growth factor β1 (TGF β1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1996; 15:404-9.
38. Rossi AG, Haslett C, Hirani N, et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF): potential role in asthma. J Clin Invest 1998; 101:2869-74.
39. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83:2759-79.
40. Li H, Chunsong H, Guobin C, et al. Highly up-regulated CXCR3 expression on eosinophils in mice infected with Schistosoma japonicum. Immunology 2004; 111:107-17.
41. de Andres B, Rakasz E, Hagen M, et al. Lack of Fc-epsilon receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 1997; 89:3826-36.